Additional sector guidance – Biotechnology and pharmaceuticals
Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Corporate Natural Capital Accounting exploratory workshops
To help understand the relevance of natural capital accounting (CCN) to accountants' toolkit and to provide input on next steps…
30×30 Progress Tracker
SkyTruth's 30x30 Progress Tracker is a tool developed in collaboration with the Bloomberg Ocean Initiative, aimed at supporting the Global…
Summary for policymakers of the methodological assessment of the diverse values and valuation of nature
IPBES launches the Summary for Policymakers of the Values Assessment and points out that one of the main reasons behind…